8.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVRX Giù?
Forum
Previsione
Precedente Chiudi:
$8.60
Aprire:
$8.64
Volume 24 ore:
194.67K
Relative Volume:
0.58
Capitalizzazione di mercato:
$213.53M
Reddito:
$47.26M
Utile/perdita netta:
$-58.48M
Rapporto P/E:
-3.0278
EPS:
-2.7049
Flusso di cassa netto:
$-40.45M
1 W Prestazione:
-1.92%
1M Prestazione:
+34.93%
6M Prestazione:
-53.91%
1 anno Prestazione:
-12.87%
Cvrx Inc Stock (CVRX) Company Profile
Nome
Cvrx Inc
Settore
Industria
Telefono
(763) 416-2850
Indirizzo
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Confronta CVRX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CVRX
Cvrx Inc
|
8.19 | 210.41M | 47.26M | -58.48M | -40.45M | -2.7049 |
![]()
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-09 | Downgrade | JP Morgan | Neutral → Underweight |
2025-01-14 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2024-09-10 | Iniziato | Cantor Fitzgerald | Overweight |
2024-07-11 | Reiterato | Lake Street | Buy |
2024-05-01 | Ripresa | Craig Hallum | Buy |
2024-05-01 | Downgrade | JP Morgan | Overweight → Neutral |
2024-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
2023-01-31 | Iniziato | Lake Street | Buy |
2022-07-18 | Iniziato | Craig Hallum | Buy |
2021-07-26 | Iniziato | Canaccord Genuity | Buy |
2021-07-26 | Iniziato | Piper Sandler | Overweight |
2021-07-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Cvrx Inc Borsa (CVRX) Ultime notizie
Is CVRx Inc. stock a growth or value playBreakthrough investment results - jammulinksnews.com
What analysts say about CVRX stockExplosive trading opportunities - jammulinksnews.com
CVRx Inc. Stock Analysis and ForecastExceptional market positioning - Autocar Professional
CVRX Stock Analysis and ForecastExplosive earnings growth - Autocar Professional
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
What analysts say about CVRx Inc. stockOutstanding capital returns - Autocar Professional
Is CVRX a good long term investmentBreakout profit opportunities - Autocar Professional
What drives CVRx Inc. stock priceMarket-beating returns - jammulinksnews.com
Is CVRx Inc. a good long term investmentSuperior investment outcomes - jammulinksnews.com
CVRx, Inc. to Release Q2 2025 Financial Results on August 4, 2025, with Conference Call to Follow - Nasdaq
CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025 - GlobeNewswire
DE-US Yields Spread And EURUSD - The Globe and Mail
Principal Financial Group Inc. Takes Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains? - MSN
why cvrx inc. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser
What risks could impact CVRX stock performance3x Growth Potential - Newser
Will CVRX stock split in the near futureStable Stocks With High Yield - Newser
Deluxe to Report Second Quarter 2025 Results on August 6, 2025 - The Globe and Mail
CVRx (CVRX) Gets a Buy from Canaccord Genuity - The Globe and Mail
CVRx announces Medicare win for Barostim therapy - MassDevice
Cvrx Inc Azioni (CVRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):